- Home
- MESA vs COEP Comparison
MESA vs COEP Comparison
Compare MESA & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MESA
- COEP
- Stock Information
- Founded
- MESA 1982
- COEP 2017
- Country
- MESA United States
- COEP United States
- Employees
- MESA N/A
- COEP N/A
- Industry
- MESA Air Freight/Delivery Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MESA Consumer Discretionary
- COEP Health Care
- Exchange
- MESA Nasdaq
- COEP Nasdaq
- Market Cap
- MESA 45.9M
- COEP 39.0M
- IPO Year
- MESA 2018
- COEP N/A
- Fundamental
- Price
- MESA $0.99
- COEP $9.31
- Analyst Decision
- MESA
- COEP
- Analyst Count
- MESA 0
- COEP 0
- Target Price
- MESA N/A
- COEP N/A
- AVG Volume (30 Days)
- MESA 206.6K
- COEP 107.6K
- Earning Date
- MESA 05-14-2025
- COEP 05-27-2025
- Dividend Yield
- MESA N/A
- COEP N/A
- EPS Growth
- MESA N/A
- COEP N/A
- EPS
- MESA N/A
- COEP N/A
- Revenue
- MESA $476,409,000.00
- COEP N/A
- Revenue This Year
- MESA $39.81
- COEP N/A
- Revenue Next Year
- MESA N/A
- COEP N/A
- P/E Ratio
- MESA N/A
- COEP N/A
- Revenue Growth
- MESA N/A
- COEP N/A
- 52 Week Low
- MESA $0.68
- COEP $2.31
- 52 Week High
- MESA $1.89
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- MESA 45.09
- COEP 49.50
- Support Level
- MESA $0.93
- COEP $7.81
- Resistance Level
- MESA $1.04
- COEP $10.86
- Average True Range (ATR)
- MESA 0.06
- COEP 1.45
- MACD
- MESA -0.01
- COEP 0.09
- Stochastic Oscillator
- MESA 22.33
- COEP 62.07
About MESA Mesa Air Group Inc.
Mesa Air Group Inc is a regional air carrier providing scheduled passenger service. It provides scheduled passenger service to 86 cities in 36 states, the District of Columbia, Canada, Cuba, and Mexico as well as cargo services out of Cincinnati/Northern Kentucky International Airport. Flights are operated as American Eagle, United Express, or DHL Express flights to the terms of capacity purchase agreements with American and United and a flight services agreement with DHL. The business has a presence in domestic hubs and cities, including Dallas, Houston, Phoenix, and Washington-Dulles and other regions.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.